Navigation Links
The Female Health Company Executes On Commitment Made At London Summit On Family Planning
Date:2/20/2013

CHICAGO, Feb. 20, 2013 /PRNewswire/ -- At the London Summit on Family Planning in July 2012, The Female Health Company (NASDAQ-CM: FHCO) announced a commitment to increase access to its FC2 Female Condom for women in the world's poorest countries.  The commitment was in response to the Summit's call for Public/Private Partnership support to achieve the goal of providing contraceptive products and related education to an additional 120 million women in 69 of the world's poorest countries by the year 2020.

(Logo: http://photos.prnewswire.com/prnh/20120712/MM39764LOGO)

The London Summit on Family Planning was hosted by the Bill and Melinda Gates Foundation and the U.K. Government with the United Nations Population Fund and other partners.

The Company has taken the following actions in reference to its three-part Public/Private Partnership commitment. 1.

Commitment: Invest up to $14 million over the next six years into reproductive health and HIV/AIDS prevention education and training initiatives in collaboration with global agencies. Action: The Company expects to spend approximately $2.3 million on education and training during FY2013. 2.

Commitment: Aggregate annual FC2 purchases from all major public sector buyers each year to establish volume-based unit pricing for the succeeding year. Action: Sales in 2012 for all major public sector customers were aggregated and volume-based pricing has been determined for calendar 2013. 3.

Commitment: Award major public sector purchasers with FC2 Female Condoms equal to 5% of their total annual units purchased, at no cost to such purchasers. Action: The Company has notified qualifying major public sector customers regarding their entitlement to 5% of the total FC2 units purchased during the initial six-month period from the start of the program o
'/>"/>

SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. The Female Health Company Reports Second Quarter Operating Results
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
6. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
7. The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
8. The Female Health Company Reports Record First Quarter FY2013 Operating Results
9. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
10. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013  NxStage Medical, Inc. (Nasdaq: ... products, today announced that it has entered into new ... in-center products to DaVita, the kidney care division of ... ) For the use of products for ... , NxStage has executed a second amended and restated ...
(Date:5/21/2013)... New data released today at the ... that the NeuroStar TMS Therapy System ® ... in patients with Major Depressive Disorder (MDD) during ... through one year of treatment.  At the end ... symptomatic improvement while 41 percent reported complete remission. ...
(Date:5/21/2013)... Quebec , May 21, 2013 ... (NYSE: VRX ) (TSX: ... ten directors nominated at its 2013 ... detailed results of the vote for ... out below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2
... Astellas Pharma US, Inc. ("Astellas") recently hired Mark ... oncology. Reporting directly to Patrick Shea, senior vice ... responsible for all U.S. commercial activities supporting marketed ... lead commercial planning for early stage development compounds. ...
... The Targetech Innovation Center, supported by a strategic ... developing pipeline of biomedical device opportunities poised to begin ... "This is an exciting development in the strategic ... effort, we will see more companies locating to Akron. ...
Cached Medicine Technology:Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise 2Akron Relationship with Israeli Incubator, Targetech, Shows Promise 2Akron Relationship with Israeli Incubator, Targetech, Shows Promise 3
(Date:5/21/2013)... Arizona State University is seeking aspiring ... their ideas into solutions, products and services in ... is recruiting participants for AREA48 (Applied Regional Economic ... early-stage entrepreneurs with opportunities to access human and ... ASU is particularly seeking participation from retirees, veterans ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 According to a ... Rethink the Use of Botox,” Botox injections have ... their approval in 2002 (Go to goo.gl/8iYbD). Although it is ... popular with men. The injection makes facial wrinkles less visible ... injection last for about three months. This means that people ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The federal ... hip replacement lawsuits in U.S. District Court, ... response to a request from Plaintiffs’ Counsel to conduct ... The May 17th Order grants that request, and ... conducted. (In re: Wright Medical Technology, Inc., Conserve Hip ...
(Date:5/21/2013)... 21, 2013 The In View ... networks and cable channels across the country, announces it ... YouTube channel. The producers of the series proudly bring ... shipping industry, the manufacturing industry, health-related companies, medical facilities ... and medical practitioners in all parts of the United ...
(Date:5/21/2013)... Phoseon Technology will present their advanced UV ... European Ink Jet Conference (June 5-6, Barcelona, Spain). ... invest in product development to enable breakthrough capability and ... in printing applications. Phoseon currently has a wide ... air cooled and water cooled solutions to match the ...
Breaking Medicine News(10 mins):Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... pneumonic plague in northern India. Doctors had feared an ... Himachal Pradesh state after several people suffered the symptoms ... collectively confirmed that the cases related to infection with ... Minister C.P. Thakur said. "The good news is that ...
... generations of birth control pills double the risk of stroke ... are no safer than the older versions when it comes ... more dangerous than the second-generation ones. ,The first ... doses of estrogen and one of two other hormones, lynestrenol ...
... genitals is mainly carried out in western and southern ... of the practice say it is done for cultural and ... potentially life-threatening - it is also an extreme form of ... The removal of the tip of the clitoris; Total removal ...
... use of novel scanning methods doctors have found that cluster headaches ... is the section that governs the body clock, which could be ... are marked by a sudden tormenting pain on one side of ... for 20 minutes to 3 hours. Affecting 0.1% of the population ...
... doctors at the research center the radioactive drug samarium destroys ... which is usually treated by surgery or chemotherapy. However, one ... ,A new radioactive drug, samarium, was tested on 21 patients ... All had failed to benefit from other treatments and had ...
... Sickle cell disease, sometimes called sickle cell anemia, is ... become sickle-shaped, which makes it difficult// for the cells ... the body's tissues. Young sickle cell patients who are ... from supplemental zinc, a mineral essential for growth and ...
Cached Medicine News:
MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...
... offers five classes of resectoscope electrodes ... loops, knife, roller bar & ball, ... only electrodes specifically integrated into the ... removal with minimal bleeding, increased visibility, ...
... and MRO™-2005 Rigid Percutaneous Nephroscopes combine ... throughput capacity with proven MRO performance. ... with small size sheaths. The MRO™-20 ... easy positioning during percutaneous procedures. The ...
... Resectoscope is based on the award winning ... the surgeon to perform TURis - resection ... element, HF cable and electrodes, Olympus OES ... in saline, supporting both, standard TUR and ...
Medicine Products: